Imprivata is proud to welcome OGiTiX Software AG as a new member of the Imprivata family, expanding the presence of Identity & Access Management solutions in DACH

Imprivata invests in combined platform to create significant operational efficiencies, improve cybersecurity, and ensure compliance for healthcare organizations in the DACH region

Berlin, 1 December 2022 - Imprivata, the digital identity company for mission- and life-critical industries, today announced the acquisition of OGiTiX Software AG, a leading provider of agile identity and access management (IAM) solutions for the DACH region. The acquisition underscores Imprivata’s commitment to helping healthcare organizations in this region improve cybersecurity while simultaneously enabling fast user access to critical data and applications.

For over 20 years, Imprivata has been helping organizations solve their toughest challenges by using identity to protect critical data and applications without workflow disruption. Its platform of solutions enable, monitor, and control all digital identities to deliver fast user access, improve security, and ensure compliance.

"Digital identity has never been more important to letting the right people in and keeping the wrong people out,” said Gus Malezis, CEO of Imprivata. “Together with OGiTiX, organizations will have a comprehensive set of tools, designed specifically for the DACH market, to automate identity management and provide fast and secure access, delivering significant operational efficiencies and organizational resilience.

Cybersecurity continues to be one of the top five issues on the agenda of healthcare institutions, an area that is identified as high priority in the 2020 Hospital Future Act (KHZG). Together, Imprivata and OGiTiX will offer the only comprehensive and tightly integrated portfolio of solutions for the DACH market to include provisioning, lifecycle and access management and single sign-on. Together, these will be the only solutions with a dedicated integration with Dedalus Orbis, the predominant Electronic Healthcare Record in the region.

"We are excited to continue to support the digitilization of healthcare organizations by solving complex process, security, and compliance challenges with identity and access management (IAM) solutions that are uniquely tailored to their needs. By combining our products and expertise with Imprivata we will provide truly comprehensive IAM solutions for our customers" adds Ingo Buck, CEO of OGiTiX.

The KHZG funding makes it possible to finance digitilization projects that have not been economically viable for most hospitals in recent years. IAM is the cornerstone of a digital identity strategy and can significantly improve the security of IT access processes. The combined Imprivata and OGiTiX unimate platforms are eligible for funding under the Hospital Future Act (KHZG) for IT security, data protection and compliance.

For more information on Imprivata’s acquisition of OGiTiX, please visit https://intl.imprivata.com/de/ogitix.

About Imprivata
Imprivata is the digital identity company for mission- and life-critical industries, redefining how organizations solve complex workflow, security, and compliance challenges solutions that product critical data and applications without workflow disruption. Its platform of identity, authentication, and access management solutions enable organizations in over 45 countries to fully manage and secure all enterprise and third-party digital identities by establishing trust between people, technology, and information. For more information, visit http://www.intl.imprivata.com/de/.

About OGiTiX
OGiTiX Software AG, based in Langenfeld (Rhineland), is a German software manufacturer that offers powerful and modular Identity & Access Management solutions. Their IAM solutions are based on our unique low-code platform OGiTiX unimate and offer easy customization and high investment security. OGiTiX supports companies worldwide in digitilization and, with its IAM solutions, increases IT security, ensures compliance and reduces process costs. For more information, visit https://www.ogitix.de/.